Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Studies with cefuroxime and cefoxitin.

A M Geddes, D McGhie, A P Ball

    Scandinavian Journal of Infectious Diseases. Supplementum
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Life after abciximab; what's next for intracoronary thrombus?

    Journal of thrombosis and thrombolysis·2019
    Same author

    Physicians and Infection.

    Journal of the Royal College of Physicians of London·2019
    Same author

    Kinematic stride cycle asymmetry is not associated with sprint performance and injury prevalence in athletic sprinters.

    Scandinavian journal of medicine & science in sports·2017
    Same author

    Antibiotic stewardship in low- and middle-income countries: the same but different?

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
    Same author

    A new look at infectious diseases: enteric Fever, salmonellosis, and food poisoning.

    British medical journal·2010
    Same author

    Influenza and bacterial pneumonia.

    International journal of antimicrobial agents·2009
    Same journal

    Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.

    Scandinavian journal of infectious diseases. Supplementum·2009
    Same journal

    Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.

    Scandinavian journal of infectious diseases. Supplementum·2009
    Same journal

    Supreme Court decision on genotypic tests for antiretroviral drugs resistance: Joint Criminal Divisions.

    Scandinavian journal of infectious diseases. Supplementum·2004
    Same journal

    Brief summary of the legal proceeding.

    Scandinavian journal of infectious diseases. Supplementum·2004
    Same journal

    Too early or too late: a never-ending dilemma with new technologies.

    Scandinavian journal of infectious diseases. Supplementum·2004
    Same journal

    Genotypic resistance tests for the management of postexposure prophylaxis.

    Scandinavian journal of infectious diseases. Supplementum·2004
    See all related articles

    Cefuroxime and cefoxitin, new cephalosporin and cephamycin antibiotics, show superior microbiological activity. Clinical trials indicate they are effective with minimal side effects for specific infections.

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Microbiology

    Background:

    • Cefuroxime is a new beta-lactamase resistant cephalosporin.
    • Cefoxitin is the first cephamycin antibiotic, resistant to many beta-lactamases.
    • Both are microbiologically superior to first-generation cephalosporins.

    Purpose of the Study:

    • To evaluate the microbiological activity and clinical efficacy of cefuroxime and cefoxitin.
    • To compare their effectiveness against specific bacterial pathogens.
    • To assess their pharmacokinetic profiles and safety.

    Main Methods:

    • Microbiological studies assessing activity against key pathogens.
    • Pharmacokinetic analysis of serum, urine, and bile concentrations after parenteral administration.

    Related Experiment Videos

  • Clinical trials evaluating efficacy and safety in patient populations.

    • Main Results:

    • Cefuroxime demonstrates notable activity against Haemophilus influenzae.
    • Cefoxitin exhibits significant activity against Bacteroides fragilis.
    • Both antibiotics achieve high concentrations in serum, urine, and bile following parenteral administration.
    • Clinical trials reported satisfactory outcomes with minimal adverse effects.

    Conclusions:

    • Cefoxitin is recommended for managing abdominal sepsis.
    • Cefuroxime is suggested for treating infections caused by Haemophilus influenzae.
    • Both antibiotics represent valuable therapeutic options in their respective indications.